Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
Domain	-	ZFP90 HIVEP2 ZNF473 ZFP57 ZNF233 ZNF112 ZNF526 ZNF33A ZNF532 ZFP64 ZNF641 ZNF324 ZNF324B ZNF443 ZNF646	4.89e-05	679	125	15	3.30.160.60
Domain	ZINC_FINGER_C2H2_2	ZFP90 HIVEP2 ZNF473 ZFP57 ZNF233 ZNF112 ZNF526 ZNF33A ZNF532 ZFP64 ZNF641 ZNF324 FOXP1 ZNF324B ZNF443 ZNF646	6.04e-05	775	125	16	PS50157
Domain	ZINC_FINGER_C2H2_1	ZFP90 HIVEP2 ZNF473 ZFP57 ZNF233 ZNF112 ZNF526 ZNF33A ZNF532 ZFP64 ZNF641 ZNF324 FOXP1 ZNF324B ZNF443 ZNF646	6.23e-05	777	125	16	PS00028
Domain	Znf_C2H2/integrase_DNA-bd	ZFP90 HIVEP2 ZNF473 ZFP57 ZNF233 ZNF112 ZNF526 ZNF33A ZNF532 ZFP64 ZNF641 ZNF324 ZNF324B ZNF443 ZNF646	6.26e-05	694	125	15	IPR013087
Domain	Znf_C2H2-like	ZFP90 HIVEP2 ZNF473 ZFP57 ZNF233 ZNF112 ZNF526 ZNF33A ZNF532 ZFP64 ZNF641 ZNF324 FOXP1 ZNF324B ZNF443 ZNF646	8.27e-05	796	125	16	IPR015880
Domain	Znf_C2H2	ZFP90 HIVEP2 ZNF473 ZFP57 ZNF233 ZNF112 ZNF526 ZNF33A ZNF532 ZFP64 ZNF641 ZNF324 FOXP1 ZNF324B ZNF443 ZNF646	9.43e-05	805	125	16	IPR007087
Domain	ZnF_C2H2	ZFP90 HIVEP2 ZNF473 ZFP57 ZNF233 ZNF112 ZNF526 ZNF33A ZNF532 ZFP64 ZNF641 ZNF324 FOXP1 ZNF324B ZNF443 ZNF646	9.85e-05	808	125	16	SM00355
Domain	KRAB	ZFP90 ZNF473 ZFP57 ZNF233 ZNF112 ZNF33A ZNF641 ZNF324 ZNF324B ZNF443	1.49e-04	358	125	10	PS50805
Domain	KRAB	ZFP90 ZNF473 ZFP57 ZNF233 ZNF112 ZNF33A ZNF641 ZNF324 ZNF324B ZNF443	1.49e-04	358	125	10	PF01352
Domain	KRAB	ZFP90 ZNF473 ZFP57 ZNF233 ZNF112 ZNF33A ZNF641 ZNF324 ZNF324B ZNF443	1.90e-04	369	125	10	SM00349
Domain	KRAB	ZFP90 ZNF473 ZFP57 ZNF233 ZNF112 ZNF33A ZNF641 ZNF324 ZNF324B ZNF443	1.94e-04	370	125	10	IPR001909
Domain	zf-C2H2	ZFP90 HIVEP2 ZNF473 ZFP57 ZNF233 ZNF112 ZNF526 ZNF33A ZFP64 ZNF641 ZNF324 ZNF324B ZNF443 ZNF646	2.25e-04	693	125	14	PF00096
Domain	zf-C2H2_6	ZFP90 ZNF473 ZNF526 ZNF532 ZFP64 ZNF324 ZNF324B ZNF443 ZNF646	2.66e-04	314	125	9	PF13912
Domain	ZnF_UBR1	UBR2 UBR4	9.13e-04	7	125	2	SM00396
Domain	ZF_UBR	UBR2 UBR4	9.13e-04	7	125	2	PS51157
Domain	zf-UBR	UBR2 UBR4	9.13e-04	7	125	2	PF02207
Domain	Znf_UBR	UBR2 UBR4	9.13e-04	7	125	2	IPR003126
Domain	EGF_LAM_2	LAMA4 LAMC3 USH2A	1.04e-03	30	125	3	PS50027
Domain	EGF_LAM_1	LAMA4 LAMC3 USH2A	1.04e-03	30	125	3	PS01248
Pubmed	N6-Methyladenosine on mRNA facilitates a phase-separated nuclear body that suppresses myeloid leukemic differentiation.	PGGHG POLM ZFP57 ATG2B TUBGCP6 ZNF526 ZNF324 FOXP1 TASOR	1.59e-07	217	132	9	34048709
Pubmed	Genetic mapping and exome sequencing identify variants associated with five novel diseases.	CRADD TUBGCP6 SNIP1	1.85e-06	7	132	3	22279524
Pubmed	UBXD7 binds multiple ubiquitin ligases and implicates p97 in HIF1alpha turnover.	DCAF1 UBR2 UBR4 HUWE1 KLHL22	3.97e-06	62	132	5	18775313
Pubmed	Novel antigen-presenting cell imparts Treg-dependent tolerance to gut microbiota.	HLA-DMA HLA-DQB2 ITGB8	4.41e-06	9	132	3	36070798
Pubmed	Human immunodeficiency virus type 1 Vpr links proteasomal degradation and checkpoint activation.	DCAF1 UBR2 UBR4	4.41e-06	9	132	3	17855541
Pubmed	Proximity-dependent biotin identification (BioID) reveals a dynamic LSD1-CoREST interactome during embryonic stem cell differentiation.	UBR4 ATG2B POLRMT HUWE1 GREB1L ZNF532 ARID5B ATF7IP2 FOXP1 TASOR	4.79e-06	418	132	10	34709266
Pubmed	Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.	DCHS2 HIVEP2 ZNF473 TMEM59 SPTBN2 UBR4 OBSL1 HUWE1 NR1D1 ITGB8 NPRL2 ZNF532 ASB3 ARID5B SMPD3 PLXNB3 ECE2	7.85e-06	1285	132	17	35914814
Pubmed	Identification and Herc5-mediated ISGylation of novel target proteins.	ERCC2 TRIM25 RGS3	1.15e-05	12	132	3	16884686
Pubmed	MERIT40 deficiency expands hematopoietic stem cell pools by regulating thrombopoietin receptor signaling.	MPL BABAM1	1.43e-05	2	132	2	25636339
Pubmed	Human endothelin converting enzyme-2 (ECE2): characterization of mRNA species and chromosomal localization.	EEF1AKMT4-ECE2 ECE2	1.43e-05	2	132	2	11718899
Pubmed	On the self-referential nature of naive MHC class II-restricted T cells.	HLA-DMA HLA-DQB2	1.43e-05	2	132	2	11086052
Pubmed	Mutations in a new gene encoding a protein of the hair bundle cause non-syndromic deafness at the DFNB16 locus.	STRC STRCP1	1.43e-05	2	132	2	11687802
Pubmed	Linkage mapping of autosomal dominant retinitis pigmentosa (RP1) to the pericentric region of human chromosome 8.	PLAT RP1	1.43e-05	2	132	2	1783394
Pubmed	Degradation of AZGP1 suppresses the progression of breast cancer cells via TRIM25.	TRIM25 AZGP1	1.43e-05	2	132	2	37927217
Pubmed	FOXP1 enhances tumor cell migration by repression of NFAT1 transcriptional activity in MDA-MB-231 cells.	NFATC2 FOXP1	1.43e-05	2	132	2	27859969
Pubmed	Dual-vector gene therapy restores cochlear amplification and auditory sensitivity in a mouse model of DFNB16 hearing loss.	STRC STRCP1	1.43e-05	2	132	2	34910522
Pubmed	The ubiquitin ligase TRIM25 targets ERG for degradation in prostate cancer.	TRIM25 UBR4 HUWE1	1.89e-05	14	132	3	27626314
Pubmed	Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.	DCAF1 IL16 ERCC2 BAG4 ANGEL1 POLRMT OBSL1 TUBGCP6 SNIP1 ZNF526 WDR20 ZNF324 FOXP1 TAF5 ZNF646	2.33e-05	1116	132	15	31753913
Pubmed	A protein interaction landscape of breast cancer.	DCAF1 UBR2 ERCC2 TRIM25 SPTBN2 UBR4 POLRMT MYO1B RIN1 SCUBE2 BABAM1	3.20e-05	634	132	11	34591612
Pubmed	Identifications of novel host cell factors that interact with the receptor-binding domain of the SARS-CoV-2 spike protein.	PCSK5 ANGEL1 POLRMT OBSL1 GRB7 NOL9 ANKRD27 RGS3 ASB3 TASOR HEATR3	4.01e-05	650	132	11	38777146
Pubmed	Human Immunodeficiency Virus Type 1 Vpr Mediates Degradation of APC1, a Scaffolding Component of the Anaphase-Promoting Complex/Cyclosome.	DCAF1 ATG2B POLRMT OBSL1 PAIP1 TASOR TOP3B	4.08e-05	242	132	7	34011540
Pubmed	CRL7SMU1 E3 ligase complex-driven H2B ubiquitylation functions in sister chromatid cohesion by regulating SMC1 expression.	DCAF1 OBSL1 HUWE1	4.18e-05	18	132	3	29507117
Pubmed	Functionality of major histocompatibility complex class II molecules in mice doubly deficient for invariant chain and H-2M complexes.	HLA-DMA HLA-DQB2	4.28e-05	3	132	2	9256469
Pubmed	Cochlear outer hair cell horizontal top connectors mediate mature stereocilia bundle mechanics.	STRC STRCP1	4.28e-05	3	132	2	30801007
Pubmed	The MHC class II molecule H2-M is targeted to an endosomal compartment by a tyrosine-based targeting motif.	HLA-DMA HLA-DQB2	4.28e-05	3	132	2	7584146
Pubmed	Activation of Dendritic Cells Alters the Mechanism of MHC Class II Antigen Presentation to CD4 T Cells.	HLA-DMA HLA-DQB2	4.28e-05	3	132	2	31996461
Pubmed	Characterization of the GNMT-HectH9-PREX2 tripartite relationship in the pathogenesis of hepatocellular carcinoma.	HUWE1 GNMT	4.28e-05	3	132	2	28205209
Pubmed	Alpha beta TCRs differ in the degree of their specificity for the positively selecting MHC/peptide ligand.	HLA-DMA HLA-DQB2	4.28e-05	3	132	2	11160279
Pubmed	The activation threshold of CD4+ T cells is defined by TCR/peptide-MHC class II interactions in the thymic medulla.	HLA-DMA HLA-DQB2	4.28e-05	3	132	2	19843939
Pubmed	H2-DMalpha(-/-) mice show the importance of major histocompatibility complex-bound peptide in cardiac allograft rejection.	HLA-DMA HLA-DQB2	4.28e-05	3	132	2	10880524
Pubmed	MHC class II regulation of CD8+ T cell tolerance and implications in autoimmunity and cancer immunotherapy.	HLA-DMA HLA-DQB2	4.28e-05	3	132	2	37976163
Pubmed	Antigen presentation by keratinocytes directs autoimmune skin disease.	HLA-DMA HLA-DQB2	4.28e-05	3	132	2	12629221
Pubmed	Somatic mutations of PREX2 gene in patients with hepatocellular carcinoma.	HUWE1 GNMT	4.28e-05	3	132	2	30796242
Pubmed	Peptide dependency of alloreactive CD4+ T cell responses.	HLA-DMA HLA-DQB2	4.28e-05	3	132	2	10221647
Pubmed	Intrinsic CD4+ T cell sensitivity and response to a pathogen are set and sustained by avidity for thymic and peripheral complexes of self peptide and MHC.	HLA-DMA HLA-DQB2	4.28e-05	3	132	2	24487322
Pubmed	Prediction of the coding sequences of unidentified human genes. VII. The complete sequences of 100 new cDNA clones from brain which can code for large proteins in vitro.	UBR2 SPTBN2 HUWE1 PLEKHM1 ZNF646	4.97e-05	104	132	5	9205841
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	PCSK5 ERCC2 HIVEP2 UBR4 POLRMT RAPGEF1 LAMC3 HUWE1 ADGRA2 PLEKHM1 UNKL ZNF324B TOP3B GAREM1	8.31e-05	1105	132	14	35748872
Pubmed	Stereocilin-deficient mice reveal the origin of cochlear waveform distortions.	STRC STRCP1	8.54e-05	4	132	2	18849963
Pubmed	A critical, invariant chain-independent role for H2-M in antigen presentation.	HLA-DMA HLA-DQB2	8.54e-05	4	132	2	9551884
Pubmed	A family of mammalian E3 ubiquitin ligases that contain the UBR box motif and recognize N-degrons.	UBR2 UBR4	8.54e-05	4	132	2	16055722
Pubmed	B cell-mediated antigen presentation is required for the pathogenesis of acute cardiac allograft rejection.	HLA-DMA HLA-DQB2	8.54e-05	4	132	2	17114442
Pubmed	The substrate recognition domains of the N-end rule pathway.	UBR2 UBR4	8.54e-05	4	132	2	19008229
Pubmed	Antigen presentation and T cell development in H2-M-deficient mice.	HLA-DMA HLA-DQB2	8.54e-05	4	132	2	8638109
Pubmed	Panel-based NGS Reveals Novel Pathogenic Mutations in Autosomal Recessive Retinitis Pigmentosa.	RP1 USH2A	8.54e-05	4	132	2	26806561
Pubmed	H2-M mutant mice are defective in the peptide loading of class II molecules, antigen presentation, and T cell repertoire selection.	HLA-DMA HLA-DQB2	8.54e-05	4	132	2	8598041
Pubmed	E3 ligases Arf-bp1 and Pam mediate lithium-stimulated degradation of the circadian heme receptor Rev-erb alpha.	HUWE1 NR1D1	8.54e-05	4	132	2	20534529
Pubmed	TRIM26 promotes non-small cell lung cancer survival by inducing PBX1 degradation.	UBR4 HUWE1	8.54e-05	4	132	2	37324936
Pubmed	Peptide specificity of thymic selection of CD4+CD25+ T cells.	HLA-DMA HLA-DQB2	8.54e-05	4	132	2	11777953
Pubmed	Loci associated with N-glycosylation of human immunoglobulin G show pleiotropy with autoimmune diseases and haematological cancers.	COL19A1 HLA-DQB2 B4GALT1 ARID5B FOXP1 USH2A	1.17e-04	199	132	6	23382691
Pubmed	Reconstitution of an operational MHC class II compartment in nonantigen-presenting cells.	HLA-DMA HLA-DQB2	1.42e-04	5	132	2	7985028
Pubmed	A genetically determined insertion/deletion related polymorphism in human T cell receptor beta chain (TCRB) includes functional variable gene segments.	TRBV4-3 TRBV4-2	1.42e-04	5	132	2	7931073
Pubmed	H2-Mbeta 1 and H2-Mbeta 2 heterodimers equally promote clip removal in I-A(q) molecules from autoimmune-prone DBA/1 mice.	HLA-DMA HLA-DQB2	1.42e-04	5	132	2	11148202
Pubmed	Calcineurin sets the bandwidth for discrimination of signals during thymocyte development.	HLA-DQB2 NFATC2	1.42e-04	5	132	2	18046413
Pubmed	Mice lacking H2-M complexes, enigmatic elements of the MHC class II peptide-loading pathway.	HLA-DMA HLA-DQB2	1.42e-04	5	132	2	8598040
Pubmed	Mechanisms governing B cell developmental defects in invariant chain-deficient mice.	HLA-DMA HLA-DQB2	1.42e-04	5	132	2	14764672
Pubmed	Invariant chain-independent function of H-2M in the formation of endogenous peptide-major histocompatibility complex class II complexes in vivo.	HLA-DMA HLA-DQB2	1.42e-04	5	132	2	9432982
Pubmed	An unusually powerful mode of low-frequency sound interference due to defective hair bundles of the auditory outer hair cells.	STRC STRCP1	1.42e-04	5	132	2	24920589
Pubmed	Cul3-KLHL20 E3 ubiquitin ligase plays a key role in the arms race between HIV-1 Nef and host SERINC5 restriction.	TRIM25 UBR4 HUWE1	1.63e-04	28	132	3	35474067
Pubmed	Time-resolved mass spectrometry of tyrosine phosphorylation sites in the epidermal growth factor receptor signaling network reveals dynamic modules.	SLC38A2 RIN1 FRK GAREM1	1.96e-04	75	132	4	15951569
Pubmed	A widely expressed betaIII spectrin associated with Golgi and cytoplasmic vesicles.	PCSK5 SPTBN2	2.12e-04	6	132	2	9826670
Pubmed	Exome sequencing of index patients with retinal dystrophies as a tool for molecular diagnosis.	RP1 USH2A	2.12e-04	6	132	2	23940504
Pubmed	HLA-DO is a lysosomal resident which requires association with HLA-DM for efficient intracellular transport.	HLA-DMA HLA-DQB2	2.12e-04	6	132	2	8890155
Pubmed	Identification of motif-based interactions between SARS-CoV-2 protein domains and human peptide ligands pinpoint antiviral targets.	ZFP90 UBR4 RGS3 PLEKHM1 PCDH11X UNKL	2.75e-04	233	132	6	37704626
Pubmed	The BRISC deubiquitinating enzyme complex limits hematopoietic stem cell expansion by regulating JAK2 K63-ubiquitination.	MPL BABAM1	2.97e-04	7	132	2	30755420
Pubmed	A new nomenclature for the laminins.	LAMA4 LAMC3	2.97e-04	7	132	2	7921537
Pubmed	Altered antigen presentation in mice lacking H2-O.	HLA-DMA HLA-DQB2	2.97e-04	7	132	2	9492004
Pubmed	The impact of H2-DM on humoral immune responses.	HLA-DMA HLA-DQB2	2.97e-04	7	132	2	11714799
Pubmed	Bridging expressed sequence alignments through targeted cDNA sequencing.	CARMIL3 ATG2B	3.94e-04	8	132	2	15028280
Pubmed	Genome-wide association study in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer risk.	PLEKHM1 BABAM1	3.94e-04	8	132	2	23544013
Pubmed	Stereocilin connects outer hair cell stereocilia to one another and to the tectorial membrane.	STRC STRCP1	3.94e-04	8	132	2	21165971
Pubmed	Activity-based E3 ligase profiling uncovers an E3 ligase with esterification activity.	UBR2 TRIM25 UBR4 HUWE1	4.83e-04	95	132	4	29643511
Pubmed	TRIM65 regulates microRNA activity by ubiquitination of TNRC6.	DCAF1 NEPRO AZGP1 BAG4 OBSL1 NOL9 TOP3B	5.00e-04	364	132	7	24778252
Pubmed	Discovery of tissue-specific exons using comprehensive human exon microarrays.	DYM RAPGEF1	5.06e-04	9	132	2	17456239
Pubmed	NEDD4L-mediated Merlin ubiquitination facilitates Hippo pathway activation.	DCAF1 HUWE1	6.31e-04	10	132	2	33058421
Pubmed	Evolutionary dynamics of non-coding sequences within the class II region of the human MHC.	HLA-DMA HLA-DQB2	6.31e-04	10	132	2	8568858
Pubmed	Trophoblast-specific expression and function of the integrin alpha 7 subunit in the peri-implantation mouse embryo.	LAMA4 LAMC3	6.31e-04	10	132	2	11784026
Pubmed	Rapid physical mapping of cloned DNA on banded mouse chromosomes by fluorescence in situ hybridization.	TRBV4-2 PLAT	6.31e-04	10	132	2	1733847
Pubmed	The integral function of the endocytic recycling compartment is regulated by RFFL-mediated ubiquitylation of Rab11 effectors.	TRIM25 USP43 MYO1B	7.20e-04	46	132	3	30659120
Pubmed	Dynamics of major histocompatibility complex class II compartments during B cell receptor-mediated cell activation.	HLA-DMA HLA-DQB2	7.69e-04	11	132	2	11854359
Pubmed	MHC class II antigen presentation pathway in murine tumours: tumour evasion from immunosurveillance?	HLA-DMA HLA-DQB2	7.69e-04	11	132	2	11027433
Pubmed	Clarin-2 is essential for hearing by maintaining stereocilia integrity and function.	STRC STRCP1	7.69e-04	11	132	2	31448880
Pubmed	Regional differences in the expression of laminin isoforms during mouse neural tube development.	LAMA4 LAMC3	7.69e-04	11	132	2	21524702
Pubmed	Mutations in LAMB1 cause cobblestone brain malformation without muscular or ocular abnormalities.	LAMA4 LAMC3	7.69e-04	11	132	2	23472759
Pubmed	Otogelin, otogelin-like, and stereocilin form links connecting outer hair cell stereocilia to each other and the tectorial membrane.	STRC STRCP1	7.69e-04	11	132	2	31776257
Pubmed	Genetic analysis of genes involved in amyloid-β degradation and clearance in Alzheimer's disease.	PLAT ECE2	9.20e-04	12	132	2	22027013
Pubmed	HIV-1 Nef impairs MHC class II antigen presentation and surface expression.	HLA-DMA HLA-DQB2	9.20e-04	12	132	2	11593029
Pubmed	Down-modulation of mature major histocompatibility complex class II and up-regulation of invariant chain cell surface expression are well-conserved functions of human and simian immunodeficiency virus nef alleles.	HLA-DMA HLA-DQB2	9.20e-04	12	132	2	12970439
Pubmed	Type II alveolar cell MHCII improves respiratory viral disease outcomes while exhibiting limited antigen presentation.	HLA-DMA HLA-DQB2	9.20e-04	12	132	2	34183650
Pubmed	HIV-1 Vpr function is mediated by interaction with the damage-specific DNA-binding protein DDB1.	UBR2 UBR4	9.20e-04	12	132	2	17360488
Pubmed	Phospho-tyrosine dependent protein-protein interaction network.	OBSL1 GRB7 HUWE1 RIN1 WDR20 ASB3 GAREM1	1.00e-03	410	132	7	25814554
Pubmed	Resolution of cell fate decisions revealed by single-cell gene expression analysis from zygote to blastocyst.	ZNF473 ZFP57 NR1D1 ZFP64 ARID5B ZNF324 FOXP1 ZNF324B UTY ZNF646	1.06e-03	808	132	10	20412781
Pubmed	Sex differences in structure and expression of the sex chromosome genes CHD1Z and CHD1W in zebra finches.	PCDH11X UTY	1.08e-03	13	132	2	14660691
Pubmed	Expression profiles of active genes in human and mouse livers.	AZGP1 MYO1B	1.26e-03	14	132	2	8863742
Pubmed	HLA class II antigens and the HIV envelope glycoprotein gp120 bind to the same face of CD4.	HLA-DMA HLA-DQB2	1.26e-03	14	132	2	7512597
Pubmed	Interaction of CD4 with HLA class II antigens and HIV gp120.	HLA-DMA HLA-DQB2	1.26e-03	14	132	2	1869305
Pubmed	Sequential genome-wide CRISPR-Cas9 screens identify genes regulating cell-surface expression of tetraspanins.	MPL IL16 POLM BAG4 NOL9 HHATL DZANK1 ZFP64 RNF139 ZNF646	1.32e-03	832	132	10	36724073
Pubmed	The deubiquitinase TRABID stabilizes the K29/K48-specific E3 ubiquitin ligase HECTD1.	UBR2 TRIM25 UBR4 POLRMT TASOR	1.33e-03	212	132	5	33853758
Pubmed	Activation of the NF-kappaB pathway by caspase 8 and its homologs.	TRIM25 CRADD	1.45e-03	15	132	2	11002417
Pubmed	HIV-1 envelope protein is expressed on the surface of infected cells before its processing and presentation to class II-restricted T lymphocytes.	HLA-DMA HLA-DQB2	1.45e-03	15	132	2	8376762
Pubmed	Basement membrane composition in the early mouse embryo day 7.	LAMA4 LAMC3	1.45e-03	15	132	2	15895400
GeneFamily	Zinc fingers C2H2-type\|ZF class homeoboxes and pseudogenes	ZFP90 HIVEP2 ZNF473 ZFP57 ZNF233 ZNF112 ZNF526 ZNF33A ZNF532 ZFP64 ZNF641 ZNF324 ZNF324B ZNF443 ZNF646	3.65e-06	718	93	15	28
GeneFamily	Ubiquitin protein ligase E3 component n-recognins	UBR2 UBR4	5.41e-04	7	93	2	785
GeneFamily	VPS9 domain containing	ANKRD27 RIN1	1.15e-03	10	93	2	928
GeneFamily	C1-set domain containing	HLA-DMA HLA-DQB2 AZGP1	1.31e-03	42	93	3	591
GeneFamily	HAD Asp-based non-protein phosphatases	NANP PHOSPHO2	1.40e-03	11	93	2	1045
GeneFamily	Laminin subunits	LAMA4 LAMC3	1.67e-03	12	93	2	626
ToppCell	10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-SMC_prolif-F\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	LAMA4 MYO1B LAMC3 ADGRA2 OR51E1 PDE5A PLAT	1.77e-06	194	131	7	a7731378f44ca1a229311686caf5740c742d21ba
ToppCell	10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-SMC_prolif\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	LAMA4 MYO1B LAMC3 ADGRA2 OR51E1 PDE5A PLAT	1.89e-06	196	131	7	9a420a4eb46cb554bec641726fea5398ff60f630
ToppCell	10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-SMC_prolif-G\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	DCHS2 LAMA4 MYO1B LAMC3 ADGRA2 OR51E1 PDE5A	1.89e-06	196	131	7	cb5860f580b477bfa52b22cdc21b808e1371e6e0
ToppCell	10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-Pericyte-C\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	LAMA4 MYO1B LAMC3 ADGRA2 ABCA9 OR51E1 PDE5A	1.89e-06	196	131	7	12d9028f90c057c6e5cff00301793fa550e86c5a
ToppCell	10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-SMC-G\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	LAMA4 MYO1B LAMC3 ADGRA2 OR51E1 PDE5A PLAT	1.96e-06	197	131	7	12370ee857fddf1cf26196b23c21b68dcea48eb3
ToppCell	10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-SMC\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	LAMA4 MYO1B LAMC3 ADGRA2 OR51E1 PDE5A PLAT	1.96e-06	197	131	7	af819b0561c8db582c5b466d804153d69d3297e0
ToppCell	tumor_Lung-Fibroblasts-Pericytes\|tumor_Lung / Location, Cell class and cell subclass	LAMA4 MYO1B LAMC3 ADGRA2 LINGO1 PDE5A	1.71e-05	183	131	6	a03dd563af9b15cb1f5de5732a229405a9f82d84
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-Pericyte\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	LAMA4 MYO1B LAMC3 ADGRA2 OR51E1 PDE5A	2.24e-05	192	131	6	09cb5b89a164ac7444774ccc8c90323c8ea2026b
ToppCell	NS-moderate-d_16-33-Epithelial-Squamous\|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	AZGP1 LAMA4 GRB7 NR1D1 ITGB8 PLAT	2.24e-05	192	131	6	103496f428f59683ac3ae6147682c07c30663724
ToppCell	critical-Lymphoid-NK\|Lymphoid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	ANO4 GALNTL6 LAMA4 ABCA9 HHATL LINGO1	2.31e-05	193	131	6	6be11fef87af04ee7a3cc223882ccd4077caded9
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	LAMA4 MYO1B LAMC3 ADGRA2 OR51E1 PDE5A	2.31e-05	193	131	6	dd4bac8a93a5b9dcf7301f1d7d6e3eb6670f5c68
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	LAMA4 MYO1B LAMC3 ADGRA2 OR51E1 PDE5A	2.31e-05	193	131	6	2ddf9b2770a0be9689e01d1a3d19e4a6d42c7a50
ToppCell	10x_3'_v2v3-Non-neoplastic-Vascular\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	LAMA4 MYO1B LAMC3 ADGRA2 OR51E1 PDE5A	2.52e-05	196	131	6	40e6900a0d56088a40d37ec312f53207ea952602
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-Scavenging_pericyte\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	LAMA4 MYO1B LAMC3 ADGRA2 OR51E1 PDE5A	2.52e-05	196	131	6	cb61757646653f89faba503cb5d99e5dd5197b4c
ToppCell	10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-Pericyte\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	LAMA4 MYO1B LAMC3 ADGRA2 OR51E1 PDE5A	2.52e-05	196	131	6	7acd782a587b7d331517f60daa8b5c2177bedfc7
ToppCell	Bronchial-NucSeq-Stromal-Schwann\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	DRD3 ITGB8 SORCS3 KCNMB4 STRC PLXNB3	2.52e-05	196	131	6	a90c76d9c57a4491b94a321ba541b792ec5d8e83
ToppCell	Fetal_brain-organoid_Tanaka_cellReport-GW09-Macroglial-Glia_progenitor_cell\|GW09 / Sample Type, Dataset, Time_group, and Cell type.	ERCC2 DIS3L2 SPTBN2 POLRMT LAMA4 PLAT	2.52e-05	196	131	6	7be50b9156394dea44d7b8b476d4dd516abfafae
ToppCell	10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-Pericyte-G\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	LAMA4 MYO1B LAMC3 ADGRA2 OR51E1 PDE5A	2.52e-05	196	131	6	73f029d2b276776d6c24356b14c6592c9cb74bd5
ToppCell	10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	LAMA4 MYO1B LAMC3 ADGRA2 OR51E1 PDE5A	2.52e-05	196	131	6	0b247cf981981ae61aca5de82ef687e8d783c9ef
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-Scavenging_pericyte-G\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	LAMA4 MYO1B LAMC3 ADGRA2 OR51E1 PDE5A	2.52e-05	196	131	6	44e2df1b61e3819eae7e482bef0a733afe852d67
ToppCell	Bronchial-NucSeq-Stromal-Schwann-Schwann_nonmyelinating\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	DRD3 ITGB8 SORCS3 KCNMB4 STRC PLXNB3	2.59e-05	197	131	6	4a7ff67bb0754e034e6f2a1bd34cde86ee3ef899
ToppCell	10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-Pericyte-F\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	LAMA4 MYO1B LAMC3 ADGRA2 OR51E1 PDE5A	2.59e-05	197	131	6	983502a99e6d59bb36225b0246a9990604de1a01
ToppCell	10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-SMC-F\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	LAMA4 MYO1B LAMC3 ADGRA2 OR51E1 PDE5A	2.59e-05	197	131	6	4a04da876a1482604452ae53c124ae68eda0bd5e
ToppCell	10x_3'_v2v3-Non-neoplastic-Endothelial-Endothelial_mature-Endo_arterial\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	LAMA4 MYO1B ADGRA2 RGS3 SHROOM4 RP1	2.74e-05	199	131	6	0602e2b2aa56d106da63bd342a38bef437b4d496
ToppCell	Transverse-Macrophage-LYVE1_Macrophage\|Macrophage / Region, Cell class and subclass	ANGEL1 ABCA9 SLC38A2 UNKL ZNF443 ECE2	2.74e-05	199	131	6	fd75dccb37d96448edf72b7d042b06833d4ead24
ToppCell	Parenchyma_COVID-19-Stromal-TX-Smooth_muscle-1\|Parenchyma_COVID-19 / Sample group, Lineage and Cell type	LAMA4 MYO1B LAMC3 ADGRA2 LINGO1 PDE5A	2.82e-05	200	131	6	78e9a40153d7ba5d9ea6393a37d26fc5c0220867
ToppCell	Lung_Parenchyma-Severe-Mesenchymal-Mesenchymal-Smooth_muscle-1\|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)	LAMA4 MYO1B LAMC3 ADGRA2 LINGO1 PDE5A	2.82e-05	200	131	6	c46e06b4f22d3456e67bc62a9ac198e8041965ad
ToppCell	Lung_Parenchyma-Severe-Mesenchymal-Mesenchymal-Smooth_muscle-1-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	LAMA4 MYO1B LAMC3 ADGRA2 LINGO1 PDE5A	2.82e-05	200	131	6	43b76e382b38b9856c07557a75e5b1ce0cee1d9e
ToppCell	LPS_anti-TNF-Mesenchymal_myocytic\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	ANO4 PCSK5 LAMA4 MYO1B PDE5A PLAT	2.82e-05	200	131	6	67dcbd86fbc79fd585d0793f979e4aac100326c9
ToppCell	LPS_only-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast\|LPS_only / Treatment groups by lineage, cell group, cell type	ANO4 PCSK5 LAMA4 ARID5B PCDH11X PDE5A	2.82e-05	200	131	6	a9ff3210127000b3dd9e97136163c98c2b0817d7
ToppCell	Parenchymal-10x5prime-Stromal-Pericyte-Muscle_pericyte_pulmonary\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	LAMA4 MYO1B LAMC3 ADGRA2 LINGO1 PDE5A	2.82e-05	200	131	6	f9bc22ff17bb1c751e6b05bca3f403836f33459a
ToppCell	Parenchymal-10x5prime-Stromal-Pericyte\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	LAMA4 MYO1B LAMC3 ADGRA2 LINGO1 PDE5A	2.82e-05	200	131	6	0a7640db28c708003d5da2d19eb651f6fedfd710
ToppCell	Hippocampus-Neuronal-Excitatory-eN1(Slc17a7)-eN1_2\|Hippocampus / BrainAtlas - Mouse McCarroll V32	RIN1 LINGO1 KCNMB4 SMPD3 GAREM1	7.43e-05	147	131	5	8f725ff8fb4ced5db2643e80669d3f7945b820ab
ToppCell	3'-GW_trimst-1.5-LargeIntestine-Mesenchymal-fibroblastic-Stromal_3_(KCNN3+)\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	DCHS2 CARMIL3 LAMC3 SCUBE2 PLAT	8.18e-05	150	131	5	909ccab92855f5f049dc29593aadab1ea973297b
ToppCell	10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-OPC-OPC-E\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	GALNTL6 CARMIL3 LAMA4 LINGO1 SORCS3	9.55e-05	155	131	5	77fdae85d36efb776db977eb424b32487ef222e4
ToppCell	5'-GW_trimst-1.5-LargeIntestine-Mesenchymal-fibroblastic-Stromal_3_(KCNN3+)\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	DCHS2 LAMC3 SCUBE2 PDE5A PLAT	1.01e-04	157	131	5	beab0ac47202266b04543c02cfcdda012375e879
ToppCell	P28-Hematopoietic-Erythroid\|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	GNMT SUV39H2 TUBGCP6 NFATC2	1.06e-04	83	131	4	e548e5c7b16c895b360a00f3d6fc1a7eb3d19294
ToppCell	P28-Hematopoietic-Erythroid-enucleate_erythrocyte\|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	GNMT SUV39H2 TUBGCP6 NFATC2	1.06e-04	83	131	4	c7ff56d4c7582fc497057cf3d5497fbd13c183cc
ToppCell	COVID-CD8-memory_CD4\|COVID / Condition, Cell_class and T cell subcluster	ERCC2 POLRMT NR1D1 ZNF324 DOP1A	1.17e-04	162	131	5	22b2a32217d357146c117e618813d451510a1801
ToppCell	5'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-tracheobronchial_goblet_cell\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	OBSL1 ABCA9 SCUBE2 SND1-IT1 ZNF443	1.32e-04	166	131	5	60060b03f2abfa3cc08107ab5a9f578e60e4ae16
ToppCell	5'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-tracheobronchial_goblet_cell-Goblet_(subsegmental)\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	OBSL1 ABCA9 SCUBE2 SND1-IT1 ZNF443	1.32e-04	166	131	5	ec9161d388db5a257b8d125c14f9dd911d5d5d4a
ToppCell	5'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-tracheobronchial_goblet_cell-Goblet_(subsegmental)-\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	OBSL1 ABCA9 SCUBE2 SND1-IT1 ZNF443	1.32e-04	166	131	5	4586d6725403f879fc96f67be579022587ce1906
ToppCell	5'-Adult-SmallIntestine-Epithelial-Tuft-related-Tuft\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	PGGHG CARMIL3 AZGP1 MYO1B ITGB8	1.39e-04	168	131	5	8072d0496b7b730c4601009eaa69ec5366d26d73
ToppCell	kidney_cells-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	COL19A1 KLRG2 ABCA9 ITGB8 RNF139	1.43e-04	169	131	5	8f397cf4f9fd7c6fa88d01a95289ce2a6bc6938d
ToppCell	facs-Diaphragm-Limb_Muscle-24m\|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HIVEP2 COL19A1 SORCS3 RP1 USH2A	1.43e-04	169	131	5	12bdc709bc000d7f9061ecd9fbd57233eaacb7e2
ToppCell	Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT2_L6_FEZF2-Exc_L6_FEZF2_KRT17\|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	PCSK5 DCHS2 COL19A1 LAMC3 PCDH11X	1.47e-04	170	131	5	84d49a1f2989d98bd0acf9ec2d59f1042fc0f55b
ToppCell	Adult-Mesenchymal-pericyte_cell-D231\|Adult / Lineage, Cell type, age group and donor	LAMA4 MYO1B LAMC3 ADGRA2 PDE5A	1.55e-04	172	131	5	858cee96c1c06160863b4adcd7023c0d678bd50f
ToppCell	343B-Lymphocytic-NK_cells-NK_cell_E\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	ATG2B ZNF526 UNKL TMEM39A SMPD3	1.64e-04	174	131	5	a1f745962a104c6f4b86b7e482da8755384c773a
ToppCell	Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT2_L6_FEZF2-Exc_L6_FEZF2_TBCC\|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	PCSK5 DCHS2 COL19A1 LAMA4 PCDH11X	1.64e-04	174	131	5	912a9e892b29d945666fc37c986009c97c668ac8
ToppCell	Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)\|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	PCSK5 DCHS2 PCDH11X SORCS3 KCNMB4	1.64e-04	174	131	5	e4d65fe121a32ac4cdd6312e7b8f867f0852e991
ToppCell	10x3'2.3-week_17-19-Neuro\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	ANO4 AZGP1 ITGB8 PLAT PLXNB3	1.68e-04	175	131	5	bbce8b1a160b414c0bf643c21c4e5e78fbccb7e1
ToppCell	343B-Lymphocytic-NK_cells-NK_cell_E\|NK_cells / Donor, Lineage, Cell class and subclass (all cells)	ATG2B ZNF526 UNKL TMEM39A SMPD3	1.68e-04	175	131	5	78a86cac3e6c0d115c997d1c29ee0e24af54551f
ToppCell	10x3'2.3-week_17-19-Neuro-stroma-schwann_cells\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	ANO4 AZGP1 ITGB8 PLAT PLXNB3	1.68e-04	175	131	5	8b010220cdfb680ec839572f4933adfb85045ea6
ToppCell	10x3'2.3-week_17-19-Neuro-stroma\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	ANO4 AZGP1 ITGB8 PLAT PLXNB3	1.68e-04	175	131	5	0b579aeadcc06be83627391c0b01bd8605fdbdf3
ToppCell	3'-Child09-12-SmallIntestine-Mesenchymal-myocytic-myofibroblast_(RSPO2+)\|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	DCHS2 COL19A1 ADGRA2 SCUBE2 PDE5A	1.73e-04	176	131	5	a8875b4ba4abf6625cdeb67bf544ce1573c59060
ToppCell	Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_5-Exc_L4-5_RORB_LINC01474\|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	LAMA4 GRB7 CCDC168 LINGO1 PCDH11X	1.73e-04	176	131	5	cd4b9211652596c42e7af318bcd464681daebb10
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	DCHS2 COL19A1 USP43 ITGB8 KCNMB4	1.78e-04	177	131	5	f30d757ee8db7e10d547498dab6560473c6ed7c0
ToppCell	Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)\|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	PCSK5 DCHS2 PCDH11X SORCS3 KCNMB4	1.78e-04	177	131	5	4c069f0d044a96118090b85ca592a21d6b5d9399
ToppCell	BAL-Severe-cDC_3\|Severe / Compartment, Disease Groups and Clusters	IL16 HLA-DQB2 ABCA9 TRBV4-2 SMPD3	1.78e-04	177	131	5	939487a05311b66edfc3f44a7955fbf25266d6bf
ToppCell	3'-GW_trimst-2-LargeIntestine-Mesenchymal-Pericytes-Immature_pericyte\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	MYO1B LAMC3 OR51E1 LINGO1 ZNF532	1.82e-04	178	131	5	e5e4742e35c3d90f82b830d77bdbdc45828c7deb
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-SMC_prolif\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	LAMA4 MYO1B LAMC3 ADGRA2 OR51E1	1.92e-04	180	131	5	64956a85c404a2ea7e4eaf6f95ebcc52c198b7cc
ToppCell	critical-Lymphoid-NK\|critical / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	ANO4 GALNTL6 ABCA9 HHATL LINGO1	1.92e-04	180	131	5	5abf778395392244daaec876f306ed7e4f388686
ToppCell	frontal_cortex-Neuronal-glutamatergic_neuron\|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	RIN1 LRRIQ1 LINGO1 FOXP1 KCNMB4	1.97e-04	181	131	5	58f76bb9ea1518c2b629a0256a3f6595a9278152
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L2-4_VIP_DSEL\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	ANO4 GALNTL6 LAMC3 PLAT ECE2	1.97e-04	181	131	5	70eff83dd85691e977972c660731394d2fcf5cdf
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-Pericyte-A\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	LAMA4 MYO1B LAMC3 ADGRA2 PDE5A	2.02e-04	182	131	5	fc4a5bf784705efe7965ce43ac23c2a8e602e90a
ToppCell	NS-critical-d_07-13-Lymphoid-NK\|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	ANO4 GALNTL6 LAMA4 ABCA9 LINGO1	2.02e-04	182	131	5	dd1c59babf7211362452e3e264009d70004d99f6
ToppCell	droplet-Limb_Muscle-Pre-Sort-18m-Macroglial-nan\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DIS3L2 ZNF473 LINGO1 PCDH11X PLXNB3	2.02e-04	182	131	5	c00e503f442d44fbae73c5e2dc85be69e294e67a
ToppCell	droplet-Lung-30m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l25\|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	ZFP57 SHROOM4 LRRIQ1 MANSC4 PLAT	2.07e-04	183	131	5	6f8f997ffc9eaebca2683de125b6069d07c07d26
ToppCell	Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)\|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	DCHS2 COL19A1 USP43 ITGB8 KCNMB4	2.07e-04	183	131	5	01ad18f198195ce341bae01a1c8c253cc4607766
ToppCell	LPS-IL1RA\|World / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	HIVEP2 RAPGEF1 B4GALT1 SHROOM4 CLIC2	2.13e-04	184	131	5	c066c2ec4f0f1d6eb183fca5c7bb0cd45c9950dc
ToppCell	droplet-Lung-30m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell\|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	PCSK5 SHROOM4 LRRIQ1 MANSC4 PLAT	2.13e-04	184	131	5	f506d0ee48f39d6f59f19554217dfdf0987cc405
ToppCell	droplet-Lung-30m-Endothelial-arterial_endothelial\|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	PCSK5 SHROOM4 LRRIQ1 MANSC4 PLAT	2.13e-04	184	131	5	8bcb1c4bc8ffef74338cdade926a94711de93c64
ToppCell	Posterior_cortex-Neuronal-Excitatory\|Posterior_cortex / BrainAtlas - Mouse McCarroll V32	HIVEP2 SPTBN2 RIN1 LRRIQ1 LINGO1	2.13e-04	184	131	5	25ccf08a8a26d7e7827b6357f33a53aaf423577d
ToppCell	Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2\|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	ANO4 GALNTL6 LAMC3 PLAT ECE2	2.13e-04	184	131	5	32473dbdb2de66391157c5814ef34e790806e4f2
ToppCell	368C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_0\|368C / Donor, Lineage, Cell class and subclass (all cells)	NANP ANGEL1 POLRMT PDE5A TOP3B	2.13e-04	184	131	5	d48807f9da48bdd015a54c606d2e2a311f181396
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1\|Children_(3_yrs) / Lineage, Cell type, age group and donor	PGGHG KLRG2 MYO1B ATF7IP2 RP1	2.18e-04	185	131	5	1c222f7285d6e3dae0354dc7e853ddc0ea55e63e
ToppCell	Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_PAX6\|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	GALNTL6 ITGB8 GREB1L SORCS3 ECE2	2.18e-04	185	131	5	79cff4f3c6ae8e5ea60e8eae082b9275f2679ee9
ToppCell	kidney_cells-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	LAMC3 ABCA9 SLC38A2 ARID5B SND1-IT1	2.18e-04	185	131	5	e1fbec55b71f604189eb2431768fadbaa0453a83
ToppCell	kidney_cells-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	LAMC3 ABCA9 SLC38A2 ARID5B SND1-IT1	2.18e-04	185	131	5	9d933cd5ebc8368fd37aa83113d2dfa6938ff72d
ToppCell	368C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_0\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	NANP ANGEL1 POLRMT PDE5A TOP3B	2.18e-04	185	131	5	7925519b855f76444a0b57382ce35d89457b0b14
ToppCell	primary_visual_cortex-Neuronal-glutamatergic_neuron\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	HIVEP2 RIN1 LINGO1 FOXP1 KCNMB4	2.23e-04	186	131	5	56c139e679d640ea901ead657a8e8887e0fca098
ToppCell	Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit\|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	USP43 LRRIQ1 LINGO1 FOXP1 KCNMB4	2.23e-04	186	131	5	84ba666237c18189d7e7556bd92dd953af733c00
ToppCell	droplet-Lung-21m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l27\|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	PCSK5 GREB1L RIN1 PLAT SMPD3	2.23e-04	186	131	5	c116cc9f41971622264434ebe29d18e719b0ae19
ToppCell	10x3'2.3-week_17-19-Endothelial-stroma-proliferating_EC\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	LAMA4 MYO1B ADGRA2 SHROOM4 SCUBE2	2.23e-04	186	131	5	a844d4f79e0ad5d6c60a4488ffd8f4f21b7eed04
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	LAMA4 LRRIQ1 SORCS3 RP1 GAREM1	2.29e-04	187	131	5	87b3d0478693d4c54ff06b74e5903036b9c1ee6a
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	LAMA4 LRRIQ1 SORCS3 RP1 GAREM1	2.29e-04	187	131	5	42a1267bfc27b4460b8409ada580a87c4385841c
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	LAMA4 LRRIQ1 SORCS3 RP1 GAREM1	2.29e-04	187	131	5	64afdea159f5e67a1e5cea35ce898aae6e80aea5
ToppCell	PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature3_(17)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	ANO4 LAMA4 MYO1B PDE5A PLAT	2.29e-04	187	131	5	a9316e2818217ec5feae9cf8816f7249803caee6
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_PAX6\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	GALNTL6 ITGB8 GREB1L SORCS3 ECE2	2.29e-04	187	131	5	d2ffb2f34f07b0dd5d3cb3ee0275f46ebecf4146
ToppCell	5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell-Pericytes-Pericytes_L.2.3.1.1\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	DCHS2 LAMA4 LAMC3 PDE5A PLAT	2.29e-04	187	131	5	8ee3bf885897efd634c3a0567637142a9f55e693
ToppCell	-Unknown-Endothelial-Myofibroblast\| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ANO4 PCSK5 CRADD SHROOM4 WDR20	2.35e-04	188	131	5	6468fa95ad0395395301115286f2d8c0df5d3882
ToppCell	-Unknown-Endothelial\| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ANO4 PCSK5 CRADD SHROOM4 WDR20	2.35e-04	188	131	5	7a81ac5c79c3eb26639b52d2b9fd5e7ef9798fd6
ToppCell	-Unknown\| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ANO4 PCSK5 CRADD SHROOM4 WDR20	2.35e-04	188	131	5	9cb718bfe1358c6fd842f096e228eb0abb9aefc6
ToppCell	343B-Lymphocytic-ILC-ILC-1\|343B / Donor, Lineage, Cell class and subclass (all cells)	DYM PGGHG NANP ZNF641 TMEM39A	2.35e-04	188	131	5	8f6b45ad82bde65e044d17f0edbc3db90d457915
ToppCell	5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_2_(NPY+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	LAMA4 LAMC3 SCUBE2 ZNF532 PLAT	2.35e-04	188	131	5	997dcfc4f08738ab398d8abc15e4fd2fc6619862
ToppCell	5'-Parenchyma_lung-Immune_Myeloid-Dendritic-conventional_dendritic_cell\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	IL16 HLA-DMA HLA-DQB2 NFATC2 CLIC2	2.35e-04	188	131	5	c39083b8020ae507246959abbb299d78bcd14042
ToppCell	5'-Parenchyma_lung-Immune_Myeloid-Dendritic-conventional_dendritic_cell-DC1_(conventional_dendritic_cell)\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	IL16 HLA-DMA HLA-DQB2 NFATC2 CLIC2	2.35e-04	188	131	5	6e7a678474715f035cc13a0e226a937688f54121
ToppCell	5'-Parenchyma_lung-Immune_Myeloid-Dendritic-conventional_dendritic_cell-DC1_(conventional_dendritic_cell)-DC1_L.1.2.1.2\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	IL16 HLA-DMA HLA-DQB2 NFATC2 CLIC2	2.35e-04	188	131	5	8862ecb87fc9b95eccc527387f2332dcc92cfdc3
ToppCell	Substantia_nigra-Endothelial\|Substantia_nigra / BrainAtlas - Mouse McCarroll V32	LAMA4 MYO1B LAMC3 ADGRA2 PDE5A	2.41e-04	189	131	5	bef8234bd9c4d6e3cdef0791d8066b39ba56ebba
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	DCHS2 LAMA4 LAMC3 ADGRA2 ABCA9	2.41e-04	189	131	5	71397e993a77d70b2eeede240bdfc7660b558987
Disease	autosomal recessive nonsyndromic deafness 16 (implicated_via_orthology)	STRC STRCP1	1.78e-05	2	125	2	DOID:0110471 (implicated_via_orthology)
Disease	peritonitis (is_implicated_in)	FOXP1 PLAT	1.77e-04	5	125	2	DOID:8283 (is_implicated_in)
Disease	allergic rhinitis	DCAF1 HLA-DQB2 LAMA4 ITGB8 NFATC2	2.62e-04	133	125	5	EFO_0005854
Disease	ovarian carcinoma	GALNTL6 ZFP90 LAMA4 PLEKHM1 BABAM1 KCNMB4 SMPD3	4.50e-04	321	125	7	EFO_0001075
Disease	interleukin 16 measurement	GALNT15 IL16 SORCS3	4.78e-04	36	125	3	EFO_0008173
Disease	response to serotonin-norephinephrine reuptake inhibitor	GALNTL6 NFATC2 ASB3	4.78e-04	36	125	3	EFO_0006325
Disease	forced expiratory volume	DIS3L2 CRADD HLA-DQB2 SPTBN2 ZFP57 ITGB8 PLEKHM1 KIAA0753 SCUBE2 FOXP1 GAREM1	5.46e-04	789	125	11	EFO_0004314
Disease	head and neck malignant neoplasia	HLA-DQB2 LAMC3	6.29e-04	9	125	2	EFO_0006859
Disease	factor VIII measurement	HLA-DQB2 SLC38A2 RP1	6.54e-04	40	125	3	EFO_0004630
Disease	clinical treatment	GALNTL6 HLA-DQB2 SORCS3	7.03e-04	41	125	3	EFO_0007056
Disease	facial morphology measurement	DCHS2 GTF2A1L CRADD HLA-DQB2 LRRIQ1 ZFP64 SORCS3 FOXP1	8.57e-04	466	125	8	EFO_0007841
Disease	ovarian serous carcinoma	LAMA4 PLEKHM1 BABAM1	9.86e-04	46	125	3	EFO_1001516
Disease	Myeloproliferative disease	MPL ATG2B	1.14e-03	12	125	2	C0027022
Disease	asthma	DCAF1 DRD3 HIVEP2 HLA-DQB2 GRB7 ITGB8 DZANK1 NFATC2 FOXP1 TASOR	1.38e-03	751	125	10	MONDO_0004979
Disease	oral cavity cancer	HLA-DQB2 LAMC3	1.57e-03	14	125	2	EFO_0005570
Disease	pulmonary hypertension (implicated_via_orthology)	NFATC2 PDE5A SMPD3	1.57e-03	54	125	3	DOID:6432 (implicated_via_orthology)
Disease	serum IgG glycosylation measurement	HIVEP2 COL19A1 HLA-DMA HLA-DQB2 B4GALT1 ARID5B FOXP1 USH2A	1.78e-03	523	125	8	EFO_0005193
Disease	response to triptolide, cytotoxicity measurement	ADGRA2 ZNF532	2.05e-03	16	125	2	EFO_0006952, EFO_0007662
Disease	Graves disease, thyrotoxic periodic paralysis	DCHS2 HLA-DQB2	2.32e-03	17	125	2	EFO_0004237, MONDO_0019201
Disease	acute kidney failure (is_marker_for)	AZGP1 PLAT	2.32e-03	17	125	2	DOID:3021 (is_marker_for)
Disease	primary biliary cirrhosis	IL16 HLA-DQB2 ITGB8 TMEM39A	2.51e-03	133	125	4	EFO_1001486
Disease	body weight	GALNTL6 PCSK5 HIVEP2 DIS3L2 GTF2A1L CRADD AZGP1 HUWE1 SLC38A2 LINGO1 NFATC2 ASB3 SMPD3	2.72e-03	1261	125	13	EFO_0004338
Disease	mitochondrial heteroplasmy measurement	HLA-DQB2 POLRMT ITGB8	3.17e-03	69	125	3	EFO_0600008
Disease	maximal midexpiratory flow rate	GALNT15 TUBGCP6	3.22e-03	20	125	2	EFO_0004313
Disease	unipolar depression, bipolar disorder, schizophrenia	PCSK5 DCHS2	3.22e-03	20	125	2	EFO_0003761, MONDO_0004985, MONDO_0005090
Disease	brain age measurement	EEF1AKMT4-ECE2 ECE2	3.22e-03	20	125	2	EFO_0010602
Disease	esophagus adenocarcinoma (is_implicated_in)	GRB7 FOXP1	3.55e-03	21	125	2	DOID:4914 (is_implicated_in)
Disease	nose morphology measurement, mouth morphology measurement	ANO4 TTLL13	3.55e-03	21	125	2	EFO_0007843, EFO_0007955
Disease	hematocrit	HIVEP2 TRIM25 HLA-DQB2 GDF2 RGS3 B4GALT1 DZANK1 ASB3 ZNF641 FOXP1 TASOR	3.86e-03	1011	125	11	EFO_0004348
Disease	intellectual disability (implicated_via_orthology)	HIVEP2 UBR4 ATF7IP2	4.01e-03	75	125	3	DOID:1059 (implicated_via_orthology)

Protein segments in the cluster

Peptide	Gene	Start	Entry
RHNFPCSVHQYESSG	BAG4	311	O95429
DHNAYRCFSQPRHIS	B4GALT1	256	P15291
QLSEHTLCAYPSALH	ADGRA2	211	Q96PE1
YHLSLHLNERCDPES	ABCA9	711	Q8IUA7
LRNHSAHNAPSYRAC	DOP1A	2076	Q5JWR5
NDCYTAPFSQQRIHH	ANO4	231	Q32M45
CGHHLPQQSLKSYND	DIS3L2	146	Q8IYB7
SPVCLQLHYKHSENR	ATG2B	641	Q96BY7
LYHQHQHSCCESPTR	POLM	361	Q9NP87
QNCPVVRPHATHSSY	RGS3	526	P49796
RLYVSCQNHVDPSHD	GDF2	151	Q9UK05
ATDYHGATPLHLACQ	ANKRD27	491	Q96NW4
LPDSGVYVCHARNAH	OBSL1	201	O75147
IHYSPTNQQLRCGSH	NFATC2	811	Q13469
HSCLSIHALHYSQPE	NOL9	171	Q5SY16
YNCHNSAITHLEPSR	DCAF1	1131	Q9Y4B6
ALESCAHPDRHYSLA	HHATL	191	Q9HCP6
AHQYHELETPCLTLS	CARF	376	Q8N187
SHLTYLNLARNSCSH	CARMIL3	391	Q8ND23
PCSRVGHIYQNQDSH	GALNT15	411	Q8N3T1
NHHNLLVCSVTDFYP	HLA-DQB2	141	P05538
ALGVQYHRDPSHSTC	ECE2	126	P0DPD6
HRSCPDHYYVEQSTQ	PCSK5	1601	Q92824
DSGLIHCQAHQFYPS	PLXNB3	741	Q9ULL4
CRSNILSHSYCLHQD	OR51E1	171	Q8TCB6
QRSEHPLAQLYCHSI	PDE5A	666	O76074
RCSGHNHVPNSLSYA	GAREM1	361	Q9H706
SSHAYCTPLNAALQA	FOXP1	561	Q9H334
CHQRARSNSTSVNPY	IL16	131	Q14005
FHPYNTCITDLRTSH	NANP	61	Q8TBE9
DVSCNLAVFYHSPIH	MANSC4	76	A6NHS7
YVRAQYQHDTSLPHC	ERCC2	141	P18074
THCNLTAVPYLAVRH	LINGO1	271	Q96FE5
HNCSNEHYPVLLSLL	TUBGCP6	511	Q96RT7
SQCIYAHRTLPHVLA	PGGHG	101	Q32M88
DHRNYDHILSTGCAP	GNMT	176	Q14749
LHHSPPSAQASALCY	PCDH11X	1231	Q9BZA7
YIACTHLHAPQEDSA	SMPD3	456	Q9NY59
AICYISSRPHSSNVN	GREB1L	1826	Q9C091
YTINPSSHCNPNHLS	HUWE1	4091	Q7Z6Z7
CSQLAPRALQATHYS	MFSD3	346	Q96ES6
VENYHTHSCNRCPKN	PHOSPHO2	136	Q8TCD6
YQQAQSRHLHPSCLG	GRB7	346	Q14451
PTIVYLDCSHNHLTD	LRRIQ1	991	Q96JM4
LCNYLSHHLTISPQS	PAIP1	221	Q9H074
DIVNLYRHSNSSGHC	DCHS2	3081	Q6V1P9
SIHPERIHNQCSDYN	ITGB8	201	P26012
SNSNGHRLCPTHVYA	NR1D1	381	P20393
CSPQSQRHGHYFVAL	FRK	36	P42685
VQYHRDPSHSTCLTE	EEF1AKMT4-ECE2	201	P0DPD8
PIHEAAYHNSVECLQ	ASB3	46	Q9Y575
PLCLSHEVHTALTNY	HEATR3	411	Q7Z4Q2
CSAYHATLPLLSHTQ	KLRG2	321	A4D1S0
QPSHPHCVNNTYRSA	KLHL22	16	Q53GT1
HPLQRPCQSHASYSL	BABAM1	301	Q9NWV8
SCLTNSLHHNPNLVY	DYM	541	Q7RTS9
EDCLYPVSHAHQRTG	COL19A1	1126	Q14993
SQTDIYRCKANHPHN	CRADD	141	P78560
PDDLQNHTFLHTVYC	HLA-DMA	36	P28067
NHTFLHTVYCQDGSP	HLA-DMA	41	P28067
RLHCPRNYVHTQLFT	GHRHR	156	Q02643
APVESYHLFLCHENS	ATF7IP2	606	Q5U623
HSDEHQLLTNPKCSY	KCNMB4	101	Q86W47
ESVPCYSQHLRFSTH	CCDC168	1996	Q8NDH2
HISAHLRCYAQNNPE	DZANK1	486	Q9NVP4
HAYLCLPRSQHEFTV	C5orf34	131	Q96MH7
RVQCSPGHFYNTTTH	SCUBE2	751	Q9NQ36
AAYVSHLPVHQDGSC	POLRMT	911	O00411
LHNAYAREEFTHTCP	CLIC2	216	O15247
LNTHCQTCHVSPELY	DRD3	351	P35462
HCHLSNSPRAIEHAY	LAMA4	1456	Q16363
SLNDAYLVPLHEHCT	RP1	1011	P56715
YLVPLHEHCTLSQSA	RP1	1016	P56715
LQRAACQCPTHSHTY	ADHFE1	16	Q8IWW8
SPVLQDHLTHLYCAS	NOXRED1	326	Q6NXP6
YHEFTTSARITPCNH	RNF139	551	Q8WU17
TSARITPCNHYFHAL	RNF139	556	Q8WU17
LSAQHISHRPCLLSY	SND1-IT1	41	Q9HBX3
AISHNSPVTLYDCHG	GALNTL6	521	Q49A17
LHGLNTSTYLHCEAP	PLEKHM1	341	Q9Y4G2
HLADVNCTRFHPNSN	TAF5	626	Q15542
HGHADNCDTTSQPYR	USH2A	521	O75445
SLSHHPVQQVYSLCL	UTY	406	O14607
THCFQHLLRVAYQDP	RIN1	621	Q13671
HPSCSKQHAVFQYRL	SNIP1	296	Q8TAD8
CYSRLDSQHSHLTLP	HPS3	561	Q969F9
CSLHLHLQLSENPYS	SORCS3	546	Q9UPU3
HCTVHRTDLYPNSKQ	NEPRO	491	Q6NW34
VCYHNPQHSALEDSS	SHROOM4	936	Q9ULL8
HTCGTTAPHYQLLKQ	WDR20	181	Q8TBZ3
PTHSSNLAIRYSCPH	KIAA0753	41	Q2KHM9
EEQSHPARLYTGCHS	NPRL2	336	Q8WTW4
PYSISNFSIHLLCQH	STRC	361	Q7RTU9
APRNKSHIDTCLHAY	TASOR	591	Q9UK61
CSFSKHHLNPLADSY	ARID5B	786	Q14865
CLHLTSVYTHFLPQR	ANGEL1	571	Q9UNK9
LHYADIQVCSRPHAR	C11orf52	76	Q96A22
LHCSHCDETYTLPQN	TOP3B	641	O95985
TPVTLRCHQTENHRY	TRBV10-3	36	A0A0K0K1G6
LLPNQCSYASHQRIH	ZNF532	791	Q9HCE3
CSYASHQRIHQHKSP	ZNF532	796	Q9HCE3
ASCHRACQLTYPLHT	TMEM59	46	Q9BXS4
HFQAQYRSSLTCPHC	USP43	241	Q70EL4
AHVRLYPSSRCTSQH	PLAT	466	P00750
TQHQRIHSGETPYAC	ZNF324	301	O75467
SRHQKAHLTEPPNYC	ZFP57	316	Q9NU63
RHCAYEHDIQALSPQ	SPTBN2	1841	O15020
NDPRIQHSSALSSCY	RAPGEF1	141	Q13905
ALLCHQESSHYISLP	GTF2A1L	231	Q9UNN4
LSHNVTENDSCRPHY	SLC38A2	271	Q96QD8
PASCTSLNFHLIDYH	TMEM39A	106	Q9NV64
RYGNVSHFVNHSCDP	SUV39H2	321	Q9H5I1
HPQRFTYCSQVLGLH	TRIM25	491	Q14258
NHRQSHTLGIYPCAI	ZNF646	256	O15015
NHRKSHQTGVYPCSL	ZNF646	391	O15015
NHRRSHETGQYSCPT	ZNF646	1316	O15015
CCTTHIANHSYLPLS	MPL	616	P40238
QYCHSRTEQQFHPES	UNKL	271	Q9H9P5
PQVSLHNASEYSHCG	ZNF33A	786	Q06730
APYSCHVQHSSLAQP	AZGP1	276	P25311
NHCSPLNTYELIHTG	ZNF112	341	Q9UJU3
HLHTLQPEDSALYLC	TRBV4-3	96	A0A589
RHETTHSAEKPYACQ	ZNF443	326	Q9Y2A4
VYARSSNQNSCLPSH	ZNF233	346	A6NK53
SRHQLTHTGARPYQC	ZNF526	516	Q8TF50
PYSISNFSIHLLCQH	STRCP1	361	A6NGW2
PYSCQHSLSFPQHSL	HIVEP2	91	P31629
SHFEHLCSYLSLPNN	UBR2	1541	Q8IWV8
HVPESAFATCLARHN	UBR4	4926	Q5T4S7
HLHTLQPEDSALYLC	TRBV4-2	96	A0A539
CPYASRNSSQLTVHL	ZFP64	236	Q9NTW7
CPYASRNSSQLTVHL	ZFP64	391	Q9NTW7
TDHQRIHTAENPYDC	ZFP90	466	Q8TF47
RHQAIHTAEKPYSCA	ZNF473	476	Q8WTR7
AHSVLRHNYRTCFPQ	TTLL13	346	A6NNM8
TQHQRIHSGETPYAC	ZNF324B	301	Q6AW86
RHQQTHTGERPYSCL	ZNF641	281	Q96N77
RCDAADPQRHHNASY	LAMC3	76	Q9Y6N6
NDTSLPHSCFRIQHY	MYO1B	501	O43795